ADVANCED OVARIAN CARCINOMA

This early-stage trial is testing the safety of combining a wearable device that uses electric fields to disrupt cancer cells with different drug combinations. It is for adults with advanced cancers in the abdomen or chest that have spread and who have run out of standard treatme…

This study is testing whether giving standard cancer treatments at home is as safe and effective as giving them in a clinic. It aims to see if receiving care at home reduces stress, improves quality of life, and is preferred by patients with advanced cancers. About 220 participan…

This study is testing whether a personalized vaccine made from a patient's own immune cells can help prevent or delay the return of advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine is designed to teach the immune system to recognize and attack cancer ce…

This is the first study in people to test a new oral drug called NKT3964. It aims to see if the drug is safe and can help control advanced cancers that have spread and stopped responding to standard treatments. The study will enroll adults with specific advanced solid tumors, inc…

This large study is testing whether a less invasive 'keyhole' surgery works as well as traditional open surgery for women with advanced ovarian, fallopian tube, or primary peritoneal cancer. All participants receive chemotherapy before surgery. Researchers want to see if the mini…

This study is testing whether taking probiotic supplements during chemotherapy can help improve gut and vaginal bacteria health in women with advanced or recurrent ovarian cancer. Researchers want to see if these supplements can reduce side effects, improve quality of life, and p…

This study is testing a telehealth program called REVITALIZE to see if it can help reduce the severe fatigue that often interferes with daily life for people with advanced ovarian cancer who are taking PARP inhibitor medications. About 240 participants will be randomly assigned t…